Trial 16M-18-2


Phase II Multi-Institutional Study of Low-Dose (4Gy) Palliative Radiotherapy in the Treatment of Symptomatic Bone metastases from Multiple Myeloma

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Radiation: External
Randomized: No
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Adam Garsa, M.D.
Other Trial Staff:  Simbiso Peresuh, Coordinator, Suraj Chandwani, D.M., Ashot Minasyan, D.M., Christine Duran, Coordinator, Donna Fernando, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.